Low-mutation-rate, reduced-genome Escherichia coli: An improved host for faithful maintenance of engineered genetic constructs

Microbial Cell Factories

Volumn 11, Issue , 2012, Pages

  Csörgo, Bálint ^a   Fehér, Tamás ^a   Tímár, Edit ^a   Blattner, Frederick R ^b,c   Pósfai, György ^a  

^a INSTITUTE OF BIOCHEMISTRY   (Hungary)

^b Scarab Genomics LLC   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Chassis; Escherichia coli; Evolvability; Mutation rate; Reduced genome; Synthetic biology

Indexed keywords

METHYLTRANSFERASE; RNA POLYMERASE; BACTERIAL PROTEIN; BACTERIOPHAGE T7 RNA POLYMERASE; DNA DIRECTED DNA POLYMERASE; DNA DIRECTED RNA POLYMERASE; VIRUS PROTEIN;

ARTICLE; BACTERIAL GENOME; BACTERIAL GROWTH; BACTERIAL STRAIN; ENZYME ACTIVITY; ESCHERICHIA COLI; GENE MUTATION; GENETIC ENGINEERING; GENETIC VARIABILITY; GROWTH INHIBITION; HOST; MUTAGENESIS; NONHUMAN; DNA REPAIR; ENZYMOLOGY; GENETICS; METABOLISM; MUTATION RATE; PLASMID;

ESCHERICHIA COLI;

BACTERIAL PROTEINS; DNA-DIRECTED DNA POLYMERASE; DNA-DIRECTED RNA POLYMERASES; ESCHERICHIA COLI; GENETIC ENGINEERING; GENOME, BACTERIAL; MUTATION RATE; PLASMIDS; SOS RESPONSE (GENETICS); VIRAL PROTEINS;

EID: 84857114878     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/1475-2859-11-11     Document Type: Article

References (70)

1. Denamur E, Matic I. Evolution of mutation rates in bacteria. Mol Microbiol 2006, 60(4):820-827. 10.1111/j.1365-2958.2006.05150.x, 16677295.
2. Endy D. Foundations for engineering biology. Nature 2005, 438(7067):449-453. 10.1038/nature04342, 16306983.
3. Chou CP. Engineering cell physiology to enhance recombinant protein production in Escherichia coli. Appl Microbiol Biotechnol 2007, 76(3):521-532. 10.1007/s00253-007-1039-0, 17571257.
4. Gao H, Zhuo Y, Ashforth E, Zhang L. Engineering of a genome-reduced host: practical application of synthetic biology in the overproduction of desired secondary metabolites. Protein Cell 2010, 1(7):621-626. 10.1007/s13238-010-0073-3, 21203934.
5. Andrianantoandro E, Basu S, Karig DK, Weiss R. Synthetic biology: new engineering rules for an emerging discipline. Mol Syst Biol 2006, 2:2006 0028. 1681505, 16738572.
6. Arbabi-Ghahroudi M, Tanha J, MacKenzie R. Prokaryotic expression of antibodies. Cancer Metastasis Rev 2005, 24(4):501-519. 10.1007/s10555-005-6193-1, 16408159.
7. Baneyx F. Recombinant protein expression in Escherichia coli. Curr Opin Biotechnol 1999, 10(5):411-421. 10.1016/S0958-1669(99)00003-8, 10508629.
8. Jana S, Deb JK. Strategies for efficient production of heterologous proteins in Escherichia coli. Appl Microbiol Biotechnol 2005, 67(3):289-298. 10.1007/s00253-004-1814-0, 15635462.
9. Jarboe LR, Zhang X, Wang X, Moore JC, Shanmugam KT, Ingram LO. Metabolic engineering for production of biorenewable fuels and chemicals: contributions of synthetic biology. J Biomed Biotechnol 2010, 2010:761042. 2857869, 20414363.
10. Meagher RB, Tait RC, Betlach M, Boyer HW. Protein expression in E. coli minicells by recombinant plasmids. Cell 1977, 10(3):521-536. 10.1016/0092-8674(77)90039-3, 403011.
11. Sorensen HP, Mortensen KK. Advanced genetic strategies for recombinant protein expression in Escherichia coli. J Biotechnol 2005, 115(2):113-128. 10.1016/j.jbiotec.2004.08.004, 15607230.
12. Terpe K. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl Microbiol Biotechnol 2006, 72(2):211-222. 10.1007/s00253-006-0465-8, 16791589.
13. Cebolla A, Royo JL, De Lorenzo V, Santero E. Improvement of recombinant protein yield by a combination of transcriptional amplification and stabilization of gene expression. Appl Environ Microbiol 2002, 68(10):5034-5041. 10.1128/AEM.68.10.5034-5041.2002, 126411, 12324354.
14. Chevalet L, Robert A, Gueneau F, Bonnefoy JY, Nguyen T. Recombinant protein production driven by the tryptophan promoter is tightly controlled in ICONE 200, a new genetically engineered E. coli mutant. Biotechnol Bioeng 2000, 69(4):351-358. 10.1002/1097-0290(20000820)69:4<351::AID-BIT1>3.0.CO;2-G, 10862673.
15. Ferrer-Miralles N, Domingo-Espin J, Corchero JL, Vazquez E, Villaverde A. Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 2009, 8:17. 10.1186/1475-2859-8-17, 2669800, 19317892.
16. Chou CH, Bennett GN, San KY. Genetic manipulation of stationary-phase genes to enhance recombinant protein production in Escherichia coli. Biotechnol Bioeng 1996, 50(6):636-642. 10.1002/(SICI)1097-0290(19960620)50:6<636::AID-BIT4>3.0.CO;2-L, 18627072.
17. Mizoguchi H, Mori H, Fujio T. Escherichia coli minimum genome factory. Biotechnol Appl Biochem 2007, 46(Pt 3):157-167.
18. Posfai G, Plunkett G, Feher T, Frisch D, Keil GM, Umenhoffer K, Kolisnychenko V, Stahl B, Sharma SS, de Arruda M, et al. Emergent properties of reduced-genome Escherichia coli. Science 2006, 312(5776):1044-1046. 10.1126/science.1126439, 16645050.
19. Lee JH, Sung BH, Kim MS, Blattner FR, Yoon BH, Kim JH, Kim SC. Metabolic engineering of a reduced-genome strain of Escherichia coli for L-threonine production. Microb Cell Fact 2009, 8:2. 10.1186/1475-2859-8-2, 2634754, 19128451.
20. Umenhoffer K, Feher T, Baliko G, Ayaydin F, Posfai J, Blattner FR, Posfai G. Reduced evolvability of Escherichia coli MDS42, an IS-less cellular chassis for molecular and synthetic biology applications. Microb Cell Fact 2010, 9:38. 10.1186/1475-2859-9-38, 2891674, 20492662.
21. Rood JI, Sneddon MK, Morrison JF. Instability in tyrR strains of plasmids carrying the tyrosine operon: isolation and characterization of plasmid derivatives with insertions or deletions. J Bacteriol 1980, 144(2):552-559. 294702, 6253437.
22. Kumar PK, Maschke HE, Friehs K, Schugerl K. Strategies for improving plasmid stability in genetically modified bacteria in bioreactors. Trends Biotechnol 1991, 9(8):279-284.
23. Amster O, Salomon D, Zamir A. A cloned immunoglobulin cDNA fragment enhances transposition of IS elements into recombinant plasmids. Nucleic Acids Res 1982, 10(15):4525-4542. 10.1093/nar/10.15.4525, 321109, 6290984.
24. Forns X, Bukh J, Purcell RH, Emerson SU. How Escherichia coli can bias the results of molecular cloning: preferential selection of defective genomes of hepatitis C virus during the cloning procedure. Proc Natl Acad Sci USA 1997, 94(25):13909-13914. 10.1073/pnas.94.25.13909, 28406, 9391126.
25. Drake JW, Charlesworth B, Charlesworth D, Crow JF. Rates of spontaneous mutation. Genetics 1998, 148(4):1667-1686. 1460098, 9560386.
26. Hall BG. Activation of the bgl operon by adaptive mutation. Mol Biol Evol 1998, 15(1):1-5.
27. Baum EZ, Bebernitz GA, Gluzman Y. Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli. Proc Natl Acad Sci USA 1990, 87(14):5573-5577. 10.1073/pnas.87.14.5573, 54367, 2196572.
28. Blumenthal RM, Cotterman MM. Isolation of mutants in a DNA methyltransferase through mcrB-mediated restriction. Gene 1988, 74(1):271-273.
29. Radman M. SOS repair hypothesis: phenomenology of an inducible DNA repair which is accompanied by mutagenesis. Basic Life Sci 1975, 5A:355-367.
30. Quillardet P, Rouffaud MA, Bouige P. DNA array analysis of gene expression in response to UV irradiation in Escherichia coli. Res Microbiol 2003, 154(8):559-572. 10.1016/S0923-2508(03)00149-9, 14527657.
31. Fernandez De Henestrosa AR, Ogi T, Aoyagi S, Chafin D, Hayes JJ, Ohmori H, Woodgate R. Identification of additional genes belonging to the LexA regulon in Escherichia coli. Mol Microbiol 2000, 35(6):1560-1572.
32. Wade JT, Reppas NB, Church GM, Struhl K. Genomic analysis of LexA binding reveals the permissive nature of the Escherichia coli genome and identifies unconventional target sites. Genes Dev 2005, 19(21):2619-2630. 10.1101/gad.1355605, 1276735, 16264194.
33. Reuven NB, Arad G, Maor-Shoshani A, Livneh Z. The mutagenesis protein UmuC is a DNA polymerase activated by UmuD', RecA, and SSB and is specialized for translesion replication. J Biol Chem 1999, 274(45):31763-31766. 10.1074/jbc.274.45.31763, 10542196.
34. Bonner CA, Randall SK, Rayssiguier C, Radman M, Eritja R, Kaplan BE, McEntee K, Goodman MF. Purification and characterization of an inducible Escherichia coli DNA polymerase capable of insertion and bypass at abasic lesions in DNA. J Biol Chem 1988, 263(35):18946-18952.
35. Tang M, Pham P, Shen X, Taylor JS, O'Donnell M, Woodgate R, Goodman MF. Roles of E. coli DNA polymerases IV and V in lesion-targeted and untargeted SOS mutagenesis. Nature 2000, 404(6781):1014-1018. 10.1038/35010020, 10801133.
36. Wagner J, Gruz P, Kim SR, Yamada M, Matsui K, Fuchs RP, Nohmi T. The dinB gene encodes a novel E. coli DNA polymerase, DNA pol IV, involved in mutagenesis. Mol Cell 1999, 4(2):281-286. 10.1016/S1097-2765(00)80376-7, 10488344.
37. Napolitano R, Janel-Bintz R, Wagner J, Fuchs RP. All three SOS-inducible DNA polymerases (Pol II, Pol IV and Pol V) are involved in induced mutagenesis. EMBO J 2000, 19(22):6259-6265. 10.1093/emboj/19.22.6259, 305832, 11080171.
38. Tippin B, Pham P, Goodman MF. Error-prone replication for better or worse. Trends Microbiol 2004, 12(6):288-295. 10.1016/j.tim.2004.04.004, 15165607.
39. Frisch RL, Su Y, Thornton PC, Gibson JL, Rosenberg SM, Hastings PJ. Separate DNA Pol II- and Pol IV-dependent pathways of stress-induced mutation during double-strand-break repair in Escherichia coli are controlled by RpoS. J Bacteriol 2010, 192(18):4694-4700. 10.1128/JB.00570-10, 2937414, 20639336.
40. Wagner J, Etienne H, Janel-Bintz R, Fuchs RP. Genetics of mutagenesis in E. coli: various combinations of translesion polymerases (Pol II, IV and V) deal with lesion/sequence context diversity. DNA Repair (Amst) 2002, 1(2):159-167.
41. Yeiser B, Pepper ED, Goodman MF, Finkel SE. SOS-induced DNA polymerases enhance long-term survival and evolutionary fitness. Proc Natl Acad Sci USA 2002, 99(13):8737-8741. 124368, 12060704.
42. Berdichevsky A, Izhar L, Livneh Z. Error-free recombinational repair predominates over mutagenic translesion replication in E. coli. Mol Cell 2002, 10(4):917-924. 10.1016/S1097-2765(02)00679-2, 12419234.
43. Lin LL, Little JW. Isolation and characterization of noncleavable (Ind-) mutants of the LexA repressor of Escherichia coli K-12. J Bacteriol 1988, 170(5):2163-2173. 211102, 2834329.
44. Cirz RT, Chin JK, Andes DR, de Crecy-Lagard V, Craig WA, Romesberg FE. Inhibition of mutation and combating the evolution of antibiotic resistance. PLoS Biol 2005, 3(6):e176. 10.1371/journal.pbio.0030176, 1088971, 15869329.
45. Foster PL. Stress-induced mutagenesis in bacteria. Crit Rev Biochem Mol Biol 2007, 42(5):373-397. 10.1080/10409230701648494, 2747772, 17917873.
46. Little JW, Edmiston SH, Pacelli LZ, Mount DW. Cleavage of the Escherichia coli lexA protein by the recA protease. Proc Natl Acad Sci USA 1980, 77(6):3225-3229. 10.1073/pnas.77.6.3225, 349587, 6447873.
47. Feher T, Karcagi I, Gyorfy Z, Umenhoffer K, Csorgo B, Posfai G. Scarless engineering of the Escherichia coli genome. Methods Mol Biol 2008, 416:251-259. 10.1007/978-1-59745-321-9_16, 18392972.
48. Feher T, Cseh B, Umenhoffer K, Karcagi I, Posfai G. Characterization of cycA mutants of Escherichia coli. An assay for measuring in vivo mutation rates. Mutat Res 2006, 595(1-2):184-190. 10.1016/j.mrfmmm.2005.11.004, 16376388.
49. Deschamps JR, Miller CE, Ward KB. Rapid purification of recombinant green fluorescent protein using the hydrophobic properties of an HPLC size-exclusion column. Protein Expr Purif 1995, 6(4):555-558. 10.1006/prep.1995.1073, 8527943.
50. Shimomura O, Johnson FH, Saiga Y. Extraction, purification and properties of aequorin, a bioluminescent protein from the luminous hydromedusan, Aequorea. J Cell Comp Physiol 1962, 59:223-239. 10.1002/jcp.1030590302, 13911999.
51. Tomasz M, Palom Y. The mitomycin bioreductive antitumor agents: cross-linking and alkylation of DNA as the molecular basis of their activity. Pharmacol Ther 1997, 76(1-3):73-87. 10.1016/S0163-7258(97)00088-0, 9535170.
52. Hoffmann F, Rinas U. Stress induced by recombinant protein production in Escherichia coli. Adv Biochem Eng Biotechnol 2004, 89:73-92.
53. Gasser B, Saloheimo M, Rinas U, Dragosits M, Rodriguez-Carmona E, Baumann K, Giuliani M, Parrilli E, Branduardi P, Lang C, et al. Protein folding and conformational stress in microbial cells producing recombinant proteins: a host comparative overview. Microb Cell Fact 2008, 7:11. 10.1186/1475-2859-7-11, 2322954, 18394160.
54. Jin DJ, Gross CA. Mapping and sequencing of mutations in the Escherichia coli rpoB gene that lead to rifampicin resistance. J Mol Biol 1988, 202(1):45-58. 10.1016/0022-2836(88)90517-7, 3050121.
55. Kwok R. Five hard truths for synthetic biology. Nature 2010, 463(7279):288-290. 10.1038/463288a, 20090726.
56. Fijalkowska IJ, Dunn RL, Schaaper RM. Mutants of Escherichia coli with increased fidelity of DNA replication. Genetics 1993, 134(4):1023-1030. 1205570, 8375645.
57. Hastings PJ, Hersh MN, Thornton PC, Fonville NC, Slack A, Frisch RL, Ray MP, Harris RS, Leal SM, Rosenberg SM. Competition of Escherichia coli DNA polymerases I, II and III with DNA Pol IV in stressed cells. PLoS One 2010, 5(5):e10862. 10.1371/journal.pone.0010862, 2877720, 20523737.
58. Lusetti SL, Cox MM. The bacterial RecA protein and the recombinational DNA repair of stalled replication forks. Annu Rev Biochem 2002, 71:71-100. 10.1146/annurev.biochem.71.083101.133940, 12045091.
59. Strauss BS, Roberts R, Francis L, Pouryazdanparast P. Role of the dinB gene product in spontaneous mutation in Escherichia coli with an impaired replicative polymerase. J Bacteriol 2000, 182(23):6742-6750. 10.1128/JB.182.23.6742-6750.2000, 111418, 11073920.
60. Nowosielska A, Janion C, Grzesiuk E. Effect of deletion of SOS-induced polymerases, pol II, IV, and V, on spontaneous mutagenesis in Escherichia coli mutD5. Environ Mol Mutagen 2004, 43(4):226-234. 10.1002/em.20019, 15141361.
61. Yamada M, Nunoshiba T, Shimizu M, Gruz P, Kamiya H, Harashima H, Nohmi T. Involvement of Y-family DNA polymerases in mutagenesis caused by oxidized nucleotides in Escherichia coli. J Bacteriol 2006, 188(13):4992-4995. 10.1128/JB.00281-06, 1482991, 16788208.
62. Blattner FR, Plunkett G, Bloch CA, Perna NT, Burland V, Riley M, Collado-Vides J, Glasner JD, Rode CK, Mayhew GF, et al. The complete genome sequence of Escherichia coli K-12. Science 1997, 277(5331):1453-1462. 10.1126/science.277.5331.1453, 9278503.
63. Miller JH. Experiments in Molecular Genetics. 1972, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
64. Chen BP, Hai T. Expression vectors for affinity purification and radiolabeling of proteins using Escherichia coli as host. Gene 1994, 139(1):73-75. 10.1016/0378-1119(94)90525-8, 8112591.
65. Timar E, Venetianer P, Kiss A. In vivo DNA protection by relaxed-specificity SinI DNA methyltransferase variants. J Bacteriol 2008, 190(24):8003-8008. 10.1128/JB.00754-08, 2593204, 18849437.
66. Sambrook J, Fritch EF, Maniatis T. Molecular Cloning. A laboratory manual. 1987, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press.
67. Warringer J, Ericson E, Fernandez L, Nerman O, Blomberg A. High-resolution yeast phenomics resolves different physiological features in the saline response. Proc Natl Acad Sci USA 2003, 100(26):15724-15729. 10.1073/pnas.2435976100, 307635, 14676322.
68. Sarkar S, Ma WT, Sandri GH. On fluctuation analysis: a new, simple and efficient method for computing the expected number of mutants. Genetica 1992, 85(2):173-179. 10.1007/BF00120324, 1624139.
69. Stewart FM, Gordon DM, Levin BR. Fluctuation analysis: the probability distribution of the number of mutants under different conditions. Genetics 1990, 124(1):175-185. 1203904, 2307353.
70. Posfai G, Koob MD, Kirkpatrick HA, Blattner FR. Versatile insertion plasmids for targeted genome manipulations in bacteria: isolation, deletion, and rescue of the pathogenicity island LEE of the Escherichia coli O157:H7 genome. J Bacteriol 1997, 179(13):4426-4428. 179272, 9209066.